Enhanced Protection for Manufacturing Highly Potent Pharmaceuticals Introduced at New Jersey Facility

Experic Expands Capabilities to Manufacture Highly Potent Drug Products

Enhanced Protection for Manufacturing Highly Potent Pharmaceuticals Introduced at New Jersey FacilityCRANBURY, N.J.; Dec. 7 2023 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, announced today the addition of a Harro Höfliger Modu-C CS Containment at its New Jersey facility. The new equipment is the first capsule-filling solution in North America to provide enhanced protection of employees and the environment from highly potent pharmaceutical products.

Many active pharmaceutical ingredients, including spray-dried powders and inhalation products, are highly potent and require manufacturers to provide a permanent physical barrier to protect operators from the material. The Modu-C CS Containment, with a completely enclosed precision filling system, protects employees from exposure and offers in-containment, inline capsule polishing, 100% gross weight control, and a wet-in-place feature to minimize exposure risk during cleaning.

“Engineering controls offer a more advanced employee protection solution in the pharmaceutical manufacturing environment,” said Justin Lacombe, Ph.D., chief scientific officer of Experic. “Combined with the advanced Harro Höfliger filling technology, Experic has a complete solution for manufacturing highly potent drug products, complementing our specialized pharmaceutical spray drying and DPI development and manufacturing services.”